Search

Linda B Tabas

from Chicago, IL
Age ~71
Get Report
Also known as:
Linda B Labas
Phone and address:
2856 W Touhy Ave UNIT B, Chicago, IL 60645
(773) 262-2330
Related to:
Mark R Halcomb, 61Michael J Wieland, 45Michael Weidemann, 44Evan WhitisWilliam WhitisAngela R Whitis, 53Emily Combs, 30
Connected to:
Gary H Tabas, 75Leah M Tabas, 37Michael J Tabas, 79Silvani B Tabas, 55Colleen A Tabasco, 62Kristina L Tabasco, 48Johnny R Tabash, 50Mary S Tabash, 66Rima Tabash, 53Bonnie P Tabasko, 45

Linda Tabas Phones & Addresses

  • 2856 W Touhy Ave UNIT B, Chicago, IL 60645 (773) 262-2330
  • 2856 Touhy Ave, Chicago, IL 60645
  • 935 Woodmere Cir, Indianapolis, IN 46260
  • 826 Park Central Ct, Indianapolis, IN 46260
  • Niles, IL
  • Carmel, IN
  • Wheeling, IL
  • 2856 W Touhy Ave UNIT B, Chicago, IL 60645

Resumes

Resumes

Linda Tabas Photo 1

Associate Director, Publications And Publications Planning

View page
Location:
Chicago, IL
Industry:
Pharmaceuticals
Work:
Synchrogenix, A Certara Company
Associate Director, Publications and Publications Planning
Eli Lilly and Company Oct 1987 - Oct 2015
Assoc Consultant Scientific Communications
Eli Lilly and Company Mar 2004 - Oct 2012
Senior Scientific Communications Assoc
Eli Lilly and Company Oct 1988 - Mar 2004
Biochemist
Education:
Northwestern University 1984 - 1987
Bachelors, Bachelor of Arts, Biology
Skills:
Pharmaceutical Industry
Clinical Trials
Life Sciences
Scientific Communications
Linda Tabas Photo 2

Senior Scientific Communications Assoc

View page
Location:
Chicago, IL
Industry:
Pharmaceuticals
Work:
Elil Lilly and Company
Senior Scientific Communications Assoc

Publications

Us Patents

Immunomethods For Isolating And Indentifying Human Influx Peptide Transporter

View page
US Patent:
6270978, Aug 7, 2001
Filed:
Jan 31, 1997
Appl. No.:
8/792485
Inventors:
Stuart W. Bright - Indianapolis IN
Anne H. Dantzig - Crawfordsville IN
Linda B. Tabas - Carmel IN
J. Richard Sportsman - Palo Alto CA
Assignee:
Eli lilly and Company - Indianapolis IN
International Classification:
G01N 3353
C07K 1400
C07K 1600
US Classification:
435 71
Abstract:
Monoclonal antibodies which react with the human influx peptide transporter are provided. The human influx peptide transporter-reactive antibodies are useful in the purification of influx peptide transporter and in immunoassays to identify agents taken up into the cell by the human influx peptide transporter mechanism.

Monoclonal Antibodies To Human Influx Peptide Transporter

View page
US Patent:
55003460, Mar 19, 1996
Filed:
Jun 29, 1993
Appl. No.:
8/084686
Inventors:
Stuart W. Bright - Indianapolis IN
Anne H. Dantzig - Crawfordsville IN
Linda B. Tabas - Carmel IN
J. Richard Sportsman - Palo Alto CA
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
G01N 33567
G01N 3353
US Classification:
435 721
Abstract:
Monoclonal antibodies which react with the human influx peptide transporter are provided. The human influx peptide transporter-reactive antibodies are useful in the purification of influx peptide transporter and in immunoassays to identify agents taken up into the cell by the human influx peptide transporter mechanism. The monoclonal antibodies are also useful for the detection and treatment of carcinomas derived from the gastrointestinal tract and pancreatic duct.

Monoclonal Antibodies To Human Influx Peptide Transporter

View page
US Patent:
58245103, Oct 20, 1998
Filed:
Dec 1, 1994
Appl. No.:
8/347760
Inventors:
Stuart W. Bright - Indianapolis IN
Anne H. Dantzig - Crawfordsville IN
Linda B. Tabas - Carmel IN
J. Richard Sportsman - Palo Alto CA
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07K 1600
C12P 1208
US Classification:
435 7021
Abstract:
Monoclonal antibodies which react with the human influx peptide transporter are provided. The human influx peptide transporter-reactive antibodies are useful in the purification of influx peptide transporter and in immunoassays to identify agents taken up into the cell by the human influx peptide transporter mechanism. The monoclonal antibodies are also useful for the detection and treatment of carcinomas derived from the gastrointestinal tract and pancreatic duct.

Diagnosis Of Colon Carcinoma Using Monoclonal Antibodies To Human Influx Peptide Transporter

View page
US Patent:
60013591, Dec 14, 1999
Filed:
Aug 12, 1997
Appl. No.:
8/909502
Inventors:
Stuart W. Bright - Indianapolis IN
Anne H. Dantzig - Crawfordsville IN
Linda B. Tabas - Carmel IN
J. Richard Sportsman - Palo Alto CA
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 39395
G01N 3353
G01N 33567
G01N 33574
US Classification:
4241781
Abstract:
Monoclonal antibodies which react with the human influx peptide transporter are provided. The human influx peptide transporter-reactive antibodies are useful in the purification of influx peptide transporter and in immunoassays to identify agents taken up into the cell by the human influx peptide transporter mechanism. The monoclonal antibodies are also useful for the detection and treatment of carcinomas derived from the gastrointestinal tract and pancreatic duct.
Control profile
Linda B Tabas from Chicago, IL, age ~71 Get Report